Inflammatory biomarker may indicate coronary lesion

08/19/2013 | MedPage Today (free registration)

A study that used intravascular ultrasound and optical coherence tomography found the biomarker pentraxin 3 could serve as a red flag that patients are at risk of heart attack, researchers argue in JACC: Cardiovascular Interventions. Also in this article, using carotid intima-media thickness to determine vascular age and combining it with the Framingham risk score could help identify patients at risk of a severe heart attack, according to a report published in the journal Echocardiography.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ